Quince Therapeutics shares jump 16.89% intraday after paying off major debt and advancing strategic options.

Quince Therapeutics surged 16.89% intraday, following the company's repayment of approximately $16.4 million in debt to the European Investment Bank with $5.5 million in cash on March 27, relieving a significant financial burden. On March 30, the company announced the completion of the debt repayment, enabling it to move forward with restructuring and evaluate strategic alternatives such as mergers, reverse mergers, or asset sales aimed at maximizing shareholder value.